Items where Author is "Bassermann, F."
![]() | Up a level |
Article
Knop, Stefan and Engelhardt, Monika and Liebisch, Peter and Meisner, Christoph and Holler, Ernst and Metzner, Bernd and Peest, Dietrich and Kaufmann, Martin and Bunjes, Donald and Straka, Christian and Fischer, Thomas and Sezer, Orhan and Hentrich, Marcus and Ostermann, Helmut and Bassermann, Florian and Hess, Georg and Hertenstein, Bernd and Freund, Mathias and Kropff, Martin and Schmidt, Christian A. and Wolf, Hans-Heinrich and Jung, Wolfram and Frickhofen, Norbert and Mielke, Stephan and Bargou, Ralf C. and Maschmeyer, Georg and Svaldi, Mirija and Langer, Christian H. and Gramatzki, Martin and Hebart, Holger and Kanz, Lothar and Einsele, Hermann and Sezer, O. and Doerken, B. and Gerecke, C. and Fuhrmann, S. and Ludwig, W. D. and Hertenstein, B. and Bormann, M. and Meyer, R. and Naumann, R. and Platzbecker, U. and Roellig, Ch and Roesler, W. and von Metzler, I and Martin, H. and Engelhardt, M. and Finke, J. and Truemper, L. and Jung, W. and Schmidt, Ch A. and Doelken, G. and Wolf, H. H. and Mueller, L. and Ligeti, K. and Kroeger, N. and Schilling, G. and Duerk, H. and Peest, D. and Ganser, A. and Pfreundschuh, M. and Sayer, H. and von Lilienfeld-Toal, M. and Muegge, L. O. and Bentz, M. and Gramatzki, M. and Brueggemann, M. and Fischer, T. and Wolleschak, D. and Hess, G. and Kropff, M. and Reusch, J. and Straka, C. and Ostermann, H. and Franke, D. and Peschel, C. and Dechow, T. and Bassermann, F. and Hentrich, M. and Wandt, H. and Schaefer-Eckart, K. and Metzner, B. and Maschmeyer, G. and Holler, E. and Hart, C. and Reichle, A. and Freund, M. and Boettcher, S. and Kahl, C. and Mergenthaler, H. G. and Aulitzky, W. and Kaufmann, M. and Greiner, J. and Heidemann, E. and Kanz, L. and Hebart, H. and Liebisch, P. and Bunjes, D. and Langer, C. and Frickhofen, N. and Einsele, H. and Knop, S. and Mielke, S. and Bargou, R. C. and Svaldi, M. (2019) Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysis. LEUKEMIA, 33 (11). pp. 2710-2719. ISSN 0887-6924, 1476-5551
Knop, S. and Langer, C. and Engelhardt, M. and Muegge, L.-O. and Reichle, A. and Roesler, W. and Bassermann, F. and Hertenstein, B. and Kunitz, A. and Roellig, C. and Ostermann, H. and Schaefer-Eckart, K. and Ringhoffer, M. and Guenther, A. and Junghanss, C. and Biersack, H. and Schreder, M. and Liebert, A. and Held, S. and Einsele, H. and Bargou, R. C. (2017) Lenalidomide, adriamycin, dexamethasone for induction followed by stem-cell transplant in newly diagnosed myeloma. LEUKEMIA, 31 (8). pp. 1816-1819. ISSN 0887-6924, 1476-5551
Conference or Workshop Item
Thiele Orberg, E. and Meedt, E. and Hiergeist, A. and Xue, J. and Heinrich, P. and Goettert, S. and Ghimire, S. and Goeldel, S. and Schwarz, A. and Herhaus, P. and Verbeek, M. and Weber, D. and Edinger, M. and Wolff, D. and Kleigrewe, K. and Herr, W. and Bassermann, F. and Gessner, A. and Deng, L. and Holler, E. and Poeck, H. (2023) Bacterial and bacteriophage consortia are associated with protective intestinal immuno-modulatory metabolites in allogeneic stem cell transplantation patients. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 13. bis 16. Oktober 2023, Hamburg, Germany.
Goettert, S. and Thiele-Orberg, E. and Fan, K. and Ghimire, S. and Mamilos, A. and Bassermann, F. and Herr, W. and Heidegger, S. and Holler, E. and Poeck, H. (2023) Immunomodulatory microbial metabolites identified in allo-SCT patients protect from GVHD by STING dependent modulation of intestinal tissue homeostasis. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 13. bis 16. Oktober 2023, Hamburg, Germany.
Stritzke, F. and Dahl, S. and Dassler-Plenker, J. and Joachim, L. and Buschmann, D. and Giebel, B. and Bassermann, F. and Coch, C. and Hartmann, G. and Heidegger, S. and Poeck, Hendrik (2022) Reprogramming the Biogenesis and immunomodulatory Function of extracellular Tumor Vesicles through Activation of the RIG-I Pathway. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien.
Thiele Orberg, E. and Goettert, S. and Hiergeist, A. and Herhaus, P. and Verbeek, M. and Gessner, A. and Herr, W. and Bassermann, F. and Holler, E. and Poeck, H. (2021) Microbial-derived metabolites induce epithelial recovery via the STING pathway in mice and men and protect from graft-versus-host disease. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 01.-04. Oktober 2021, Berlin, Germany.
Enssle, S. and Perl, M. and Nedelko, T. and Krieger, M. and Bassermann, F. and Poeck, H. and Heidegger, S. (2021) Tumor cell-intrinsic Gasdermin E (GSDME) activation contributes to checkpoint inhibitor-mediated anticancer immunity. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 01.-04. Oktober 2021, Berlin, Germany.
Stritzke, F. and Joachim, L. and Bek, S. and Nedelko, T. and Bassermann, F. and Heidegger, S. and Poeck, H. (2020) Tumor-intrinsic RIG-I signaling modulates immunogenicity of tumor cell-derived extracellular vesicles that can mediate T cell-based antitumor immunity. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020, Virtuell.
Other
Knop, S. and Langer, C. and Engelhardt, M. and Stuebig, T. and Schreder, M. and Dechow, T. and Muegge, L. -O. and Bassermann, F. and Schaefer-Eckart, K. and Blau, I. -W. and Wolleschak, D. and Kropff, M. and Reichle, A. and von Metzler, I. and Metzner, B. and Roellig, C. and Hertenstein, B. and Pfreundschuh, M. and Duerk, H. and Biersack, H. and Ostermann, H. and Menzel, H. and Schleicher, J. and Gramatzki, M. and Gerecke, C. and Mueller, M. and Brueggemann, M. and Held, S. and Einsele, H. (2017) Lenalidomide, adriamycin and dexamethasone (RAD) versus bortezomib, lenalidomide and dexamethasone (VRD) as induction regimens in newly diagnosed multiple myeloma - first results from the DSMM XIV study. KARGER, BASEL.
Einsele, H. and Vogel, M. and Mueller, J. and Knop, S. and Kropff, M. and Langer, C. and Sayer, H. and Jung, W. and Wandt, H. and Bassermann, F. and Gramatzki, M. and Roesler, W. and Brugger, W. and Engelhardt, M. and Fischer, T. and Giagounidis, A. and Heidemann, E. and Kroeger, N. and Sezer, O. and Bentz, M. and Pfreundschuh, M. and Salwender, H. and Ludwig, W. -D. and Roellig, C. and Staib, P. and Runde, V. and Scheid, C. and Ostermann, H. and Hess, G. and Hebart, H. and Repp, R. and Hart, C. and Frickhofen, N. and Straka, C. and Pflueger, K. -H. (2015) RESULTS FROM TWO PHASE 3 STUDIES OF POST-TRANSPLANT BORTEZOMIB (BTZ) CONSOLIDATION VS OBSERVATION (OBS) IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM). FERRATA STORTI FOUNDATION, PAVIA.
Lorenzen, S. and Helbig, U. and Knorrenschild, Riera J. and Haag, G. M. and Pohl, M. and Thuss-Patience, P. and Bassermann, F. and Weissinger, F. and Schnoy, E. and Becker, K. and Rueschoff, J. and Eisenmenger, A. and Karapanagiotou-Schenkel, I and Lordick, F. (2014) Lapatinib versus Lapatinib plus Capecitabine as secondline treatment in Her2-Overexpressing Metastatic Gastro-Esophageal Cancer (GC): A randomized phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO). KARGER, BASEL.
Knop, S. and Langer, C. and Engelhardt, M. and Muegge, L-O and Roesler, W. and Reichle, A. and Roellig, C. and Hertenstein, B. and Gramatzki, M. and Bassermann, F. and Ostermann, H. and Sturm, I and Ringhoffer, M. and Schaefer-Eckart, K. and Falk, K. and Liebert, A. and Einsele, H. and Bargou, R. (2013) Lenalidomide, Adriamycin, Dexamethasone (RAD) followed by risk-adjusted transplant is a novel and very effective induction regimen in newly diagnosed multiple myeloma. KARGER, BASEL.

